港通医疗(301515.SZ)发布前三季度业绩，归母净亏损1020.84万元

Core Viewpoint - 港通医疗 reported a significant decline in revenue and incurred net losses in the first three quarters of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters was 344 million yuan, representing a year-on-year decrease of 30.06% [1] - The net loss attributable to shareholders of the listed company was 10.21 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 12.87 million yuan [1] - The basic loss per share was 0.1054 yuan [1]